Advertisement
For patients with chronic conditions

Many Patients Using E-Mail As First Method of Provider Contact

0
Online communications reduced need for phone calls and office visits for many
For men with prostate cancer

ASCO: Aspirin Use Linked to Lower Risk of Lethal Prostate CA

0
Risk of prostate cancer mortality reduced with regular aspirin use after diagnosis
Initial diagnostic characteristics may be able to identify men initiating active surveillance who could avoid confirmatory biopsy

Diagnostic Factors May Help Patients Avoid Prostate Biopsy

0
Prostate-specific antigen density, total tumor length are significant predictors

December 2015 Briefing – Urology

0
Here are what the editors at HealthDay consider to be the most important developments in Urology for December 2015. This roundup includes the latest...
Physician burnout is the top issue for physicians in 2015

AMA: Burnout Is Top Issue for Physicians in 2015

0
More than half of docs report at least one symptom of burnout; efforts being undertaken to address burnout
Patients undergoing prostate needle biopsies after the 2012 U.S. Preventive Services Task Force recommendation against prostate-specific antigen-based screening for prostate cancer for men of any age are more likely to be diagnosed with high-risk disease

Impact of 2012 USPSTF Guideline Against PSA Screening Explored

0
After, men undergoing prostate needle biopsy more likely to be diagnosed with high-risk disease
For men with metastatic prostate cancer

More Adverse Effects for Medical Castration in Prostate Cancer

0
Higher risks of several clinically relevant adverse effects compared with surgical castration
For patients with end-stage renal disease

PSA Screening May Be Harmful for Patients With ESRD

0
Screening not linked to improved patient survival after transplant; may delay time to listing, transplant
For patients undergoing mid urethral sling surgery

Pre-Op Testing Over, Under Used in Mid Urethral Sling Surgery

0
Preoperative testing overused and underused; estimated charge of overused testing, $18/patient
Azithromycin is not noninferior to doxycycline for treatment of urogenital chlamydia infection among adolescents; however

Efficacy of Azithromycin in Chlamydia Remains High

0
Although study did not establish noninferiority of azithromycin versus doxycycline